Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Neuroendocrinology in 2011].
Puig Domingo M, Castaño J, Alvarez-Escolá C, Resmini E, Venegas E, García Arnés J, Torres E, Lecumberri B, Barahona MJ, Lamas C, Fajardo C, Cámara R, Vicente A, Blanco C, Villabona C, Del Pozo C, Halperin I, Salinas I, Sesmilo G, Aller J, Marazuela M, Webb SM, Bernabeu I. Puig Domingo M, et al. Among authors: venegas e. Endocrinol Nutr. 2012 May;59(5):311-25. doi: 10.1016/j.endonu.2012.01.009. Epub 2012 Mar 16. Endocrinol Nutr. 2012. PMID: 22425316 Spanish. No abstract available.
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA).
Sesmilo G, Gaztambide S, Venegas E, Picó A, Del Pozo C, Blanco C, Torres E, Álvarez-Escolà C, Fajardo C, García R, Cámara R, Bernabeu I, Soto A, Villabona C, Serraclara A, Halperin I, Alcázar V, Palomera E, Webb SM; REA investigators. Sesmilo G, et al. Among authors: venegas e. Pituitary. 2013 Mar;16(1):115-21. doi: 10.1007/s11102-012-0384-x. Pituitary. 2013. PMID: 22481632
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.
Puig-Domingo M, Soto A, Venegas E, Vilchez R, Blanco C, Cordido F, Lucas T, Marazuela M, Casany R, Cuatrecasas G, Fajardo C, Gálvez MÁ, Maraver S, Martín T, Romero E, Paja M, Picó A, Bernabeu I, Resmini E; ACROCOMB study group. Puig-Domingo M, et al. Among authors: venegas e. Endocrinol Nutr. 2016 Oct;63(8):397-408. doi: 10.1016/j.endonu.2016.05.010. Epub 2016 Jul 20. Endocrinol Nutr. 2016. PMID: 27448708 Free article. English, Spanish.
Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly.
Bernabéu I, Fajardo C, Marazuela M, Cordido F, Venegas EM, de Pablos-Velasco P, Maroto GP, Olvera MP, de Paz IP, Carvalho D, Romero C, De la Cruz G, Escolá CÁ. Bernabéu I, et al. Among authors: venegas em. Endocrine. 2020 Dec;70(3):575-583. doi: 10.1007/s12020-020-02424-z. Epub 2020 Jul 28. Endocrine. 2020. PMID: 32725444 Free PMC article.
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly.
Ruiz S, Gil J, Biagetti B, Venegas E, Cámara R, Garcia-Centeno R, Gálvez MÁ, Picó A, Maraver S, González I, Abellán P, Trincado P, Herrera M, Olvera P, Xifra G, Bernabeu I, Serra-Soler G, Azriel S, García L, Carvalho D, Jordà M, Valassi E, Puig J, Puig-Domingo M. Ruiz S, et al. Among authors: venegas e. Clin Endocrinol (Oxf). 2023 Oct;99(4):378-385. doi: 10.1111/cen.14946. Epub 2023 Jul 8. Clin Endocrinol (Oxf). 2023. PMID: 37421211
47 results